122 related articles for article (PubMed ID: 31615696)
1. Design, synthesis and evaluation of structurally diverse chrysin-chromene-spirooxindole hybrids as anticancer agents.
Zhang WH; Chen S; Liu XL; Feng TT; Yang WD; Zhou Y
Bioorg Med Chem; 2019 Nov; 27(22):115109. PubMed ID: 31615696
[TBL] [Abstract][Full Text] [Related]
2. Regioselective synthesis and evaluation of 2-amino 3-cyano chromene-chrysin hybrids as potential anticancer agents.
Wang HJ; Zhou YY; Liu XL; Zhang WH; Chen S; Liu XW; Zhou Y
Bioorg Med Chem Lett; 2020 May; 30(9):127087. PubMed ID: 32160978
[TBL] [Abstract][Full Text] [Related]
3. Study on antitumor activities of the chrysin-chromene-spirooxindole on Lewis lung carcinoma C57BL/6 mice in vivo.
Zhang WH; Chen S; Liu XL; Bing-Lin ; Liu XW; Zhou Y
Bioorg Med Chem Lett; 2020 Sep; 30(17):127410. PubMed ID: 32738990
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
5. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
[TBL] [Abstract][Full Text] [Related]
6. In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents.
Debnath S; Kanakaraju M; Islam M; Yeeravalli R; Sen D; Das A
Comput Biol Chem; 2019 Dec; 83():107156. PubMed ID: 31710991
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anticancer evaluation of novel spirobenzo[h]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities.
Abdelatef SA; El-Saadi MT; Amin NH; Abdelazeem AH; Omar HA; Abdellatif KRA
Eur J Med Chem; 2018 Apr; 150():567-578. PubMed ID: 29549841
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of chrysin benzimidazole derivatives as potential anticancer agents.
Wang Z; Deng X; Xiong S; Xiong R; Liu J; Zou L; Lei X; Cao X; Xie Z; Chen Y; Liu Y; Zheng X; Tang G
Nat Prod Res; 2018 Dec; 32(24):2900-2909. PubMed ID: 29063798
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
[TBL] [Abstract][Full Text] [Related]
10. Facile Synthesis and Cytotoxicity of Phenazine-Chromene Hybrid Molecules Derived from Phenazine Natural Product.
Zhang MC; Gu SH; Liu GP; Li CC; Xu HM; Wu ZX; Ye BP; Lu YY; Huang DC; Wang ZX; Jiang F
Comb Chem High Throughput Screen; 2019; 22(1):35-40. PubMed ID: 30848195
[TBL] [Abstract][Full Text] [Related]
11. A domino Knoevenagel hetero-Diels-Alder reaction for the synthesis of polycyclic chromene derivatives and evaluation of their cytotoxicity.
Reddy BV; Divya B; Swain M; Rao TP; Yadav JS; Vishnu Vardhan MV
Bioorg Med Chem Lett; 2012 Mar; 22(5):1995-9. PubMed ID: 22330634
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-promoted copper-catalyzed synthesis of bis-arylselanyl chrysin derivatives with boosted antioxidant and anticancer activities.
Fonseca SF; Padilha NB; Thurow S; Roehrs JA; Savegnago L; de Souza MN; Fronza MG; Collares T; Buss J; Seixas FK; Alves D; Lenardão EJ
Ultrason Sonochem; 2017 Nov; 39():827-836. PubMed ID: 28733012
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary biological evaluation of chrysin derivatives as potential anticancer drugs.
Zheng X; Zhao FF; Liu YM; Yao X; Zheng ZT; Luo X; Liao DF
Med Chem; 2010 Jan; 6(1):6-8. PubMed ID: 20402655
[TBL] [Abstract][Full Text] [Related]
14. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity evaluation of novel chrysin-organotin compound in MCF-7 cells.
Xuan HZ; Zhang JH; Wang YH; Fu CL; Zhang W
Bioorg Med Chem Lett; 2016 Jan; 26(2):570-574. PubMed ID: 26670842
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity evaluation of chrysin derivatives.
Zhu ZY; Wang WX; Wang ZQ; Chen LJ; Zhang JY; Liu XC; Wu SP; Zhang YM
Eur J Med Chem; 2014 Mar; 75():297-300. PubMed ID: 24556144
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
Suresh Babu K; Hari Babu T; Srinivas PV; Hara Kishore K; Murthy US; Rao JM
Bioorg Med Chem Lett; 2006 Jan; 16(1):221-4. PubMed ID: 16213726
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
[TBL] [Abstract][Full Text] [Related]
19. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
20. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition.
Ren SZ; Wang ZC; Zhu XH; Zhu D; Li Z; Shen FQ; Duan YT; Cao H; Zhao J; Zhu HL
Bioorg Med Chem; 2018 Aug; 26(14):4264-4275. PubMed ID: 30031652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
